1 Egloff SAA,Du L,Loomans HA,et al.Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer[J].Oncotarget,2016,8(1):722-741. 2 Ribeiro KB,da Silva Zanetti J,Ribeiro-Silva A.KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer[J].Cancer Biomark,2016,16(4):513-521. 3 Andisheh-Tadbir A,Ashraf MJ,Khademi B,et al.Clinical implication of CD166 expression in salivary gland tumor[J].Tumour Biol,2015,36(4),2793-2799. 4 Tadbir A,Ashraf MJ,Khademi B,et al.Clinical implication of CD166 expression in salivary gland tumor[J].Tumour Biol,2015,36(4):2793-2799. 5 Zhang WW,Zhan SH,Geng CX,et al.Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells[J].Mol Med Rep,2016,14(4):3627-3633. 6 Wachowiak R,Mayer S,Kaifi J,et al.Prognostic impact of activated leucocyte cell adhesion molecule(ALCAM/CD166)in infantile neuroblastoma[J].Anticancer Res,2016,36(8):3991-3995. 7 Chen MJ,Cheng YM,Chen CC,et al.MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM[J].Biochem Biophys Res Commun,2017,483(2):840-846. 8 梁淑美.ALCAM在子宫内膜恶性转化中的作用[D].山东:山东大学,2011. 9 Ihnen M,Kress K,Kersten JF,et al.Relevance of activated leukocyte cell adhesion molecule(ALCAM)in tumor tissue and sera of cervical cancer patients[J].BMC Cancer,2012,12:140. 10 Ikeda K,Quertermous T.Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function[J].J Biol Chem,2004,279(53):55315-55323. 11 Hassan NJ,Barclay AN,Brown MH.Optimal T cell activation requires the engagement of CD6 and CD166[J].Eur J Immunol,2004,34(4):930-940. 12 Tudor C,Te Riet J,Eich C,et al.Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton[J].J Biol Chem,2014,289(19):13445-13460. 13 Tan F,Mbunkui F,Ofori-Acquah SF.Cloning of the human activated leukocyte cell adhesion molecule promoter and identification of its tissue-independent transcriptional activation by Sp1[J].Cell Mol Biol Lett,2012,17(4):571-585. 14 Akman HB,Selcuklu SD,Donoghue MTA,et al.ALCAM is indirectly modulated by miR-125b in MCF7 cells[J].Tumor Biol,2015,36(5):3511-3520. 15 Sawhney M,Matta A,Macha MA,et al.Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients[J].Int J Cancer,2009,124:2098-2105. 16 Hansen AG,Hebron K,Palmer TD,et al.Abstract B65:Proteolytic shedding of the cell adhesion molecule ALCAM generates a spatial and context-dependent heterogeneity important for metastasis[J].Cancer Res,2015,75(Suppl):65. 17 Carbotti G,Orengo AM,Mezzanzanica D,et al.Activated leukocyte cell adhesion molecule soluble form:A potential biomarker of epithelial ovarian cancer is increased in type II tumors[J].Int J Cancer,2013,132(11),2597-2605. 18 Chaker S,Kak I,MacMillan C,et al.Activated leukocyte cell adhesion molecule is a marker for thyroid carcinoma aggressiveness and disease-free survival[J].Thyroid,2013,23(2):201-208. 19 Xiao M,Wang X,Yan M,et al.A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker[J].Expert Rev Mol Diagn,2016,16(9):925-932. 20 Liang SM,Huang CP,Jia SZ,et al.Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma[J].Int J Gynecol Cancer,2011,21:523-528. 21 Devis L,Moiola CP,Masia N,et al.Activated leukocyte cell adhesion molecule(ALCAM)is a marker of recurrence and promotes cell migration,invasion and metastasis in early stage endometrioid endometrial cancer[J].J Pathol,2017,241(4):475-487. 22 Lozneanu L,Cojocaru E,Giu?c? SE,et al.Lesser-known molecules in ovarian carcinogenesis[J].Biomed Res Int,2015,2015:321740. 23 Mezzanzanica D,Fabbi M,Bagnoli M,et al.Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients[J].Clin Cancer Res,2008,14:1726-1733. 24 Rosso O,Piazza T,Bongarzone I,et al.The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells[J].Molecular Cancer Research,2007,5(12):1246-1253. 25 Carbotti G,Orengo AM,Mezzanzanica D,et al.Activated leukocyte cell adhesion molecule soluble form:a potential biomarker of epithelial ovarian cancer is increased in type II tumors[J].Int J Cancer,2013,132(11):2597-2605. 26 Chan JK,Kiet TK,Blansit K,et al.MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer[J].Gynecol Oncol,2014,133(3):568-574. 27 Hein S,Müller V,Khler N,et al.Biological role of activated leukocyte cell adhesion molecule(ALCAM)overexpression in breast cancer cell lines and clinical tumour tissue[J].Breast Cancer Res Treatm,2011,129(2):347-360. |